International Clinical Trial: Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462507) titled 'Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1' on March 4.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Washington University School of Medicine

Condition: Central Nervous System Cancer Brain Metastases

Intervention: Drug: [C-11]-CS1P1

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: March 31, 2026

Target Sample Size: 104

Countries of Recruitment: United States

To know more, visit https://cl...